Diageo PLC
04 February 2004
4 February 2004
Diageo 2003 US GAAP financial information
Diageo has today filed with the SEC an amendment to the US GAAP financial
information included in Diageo's 2003 Annual Report on Form 20-F. The amendment
relates to the US GAAP treatment of deferred tax associated with pension
liabilities.
The amendment results in a deferred tax charge of £53 million being reclassified
from other comprehensive deficit to net income and a reversal of deferred tax of
£118 million previously charged to other comprehensive deficit. The overall
effect is therefore a reduction of £53 million in net income as reported under
US GAAP, a reduction in the comprehensive deficit of £118 million and an
increase in shareholders equity of £118 million.
The amendment does not affect Diageo's principal financial information prepared
under UK GAAP nor does it affect operating income or cash flow under US GAAP.
-ends-
Media enquiries Ian Wright +44 (0)20 7927 5302 Media@diageo.com
Investor enquiries Catherine James +44(0)20 7927 5272 Investor.rel@diageo.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.